Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like FDA Attributes Savings of $11.8 Billion in Drug Costs to Generics June 5, 2018 AdComm Process Is ‘Messy’ but Necessary and Needs Reform, Califf Says February 9, 2023 Stakeholders Ask FDA to Clarify Guidance on ‘Indications and Usage’ in Labeling September 11, 2018